Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 20, 2023

SELL
$86.06 - $137.93 $516 - $827
-6 Reduced 10.0%
54 $5,000
Q2 2023

Jul 25, 2023

BUY
$112.47 - $130.98 $6,748 - $7,858
60 New
60 $7,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Maryland Capital Advisors Inc. Portfolio

Follow Maryland Capital Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland Capital Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Maryland Capital Advisors Inc. with notifications on news.